Influence of body position on defecation mechanics measured during high-resolution anorectal manometry in paediatric population: a protocol for case-control study Authors: Barbara Skowrońska, Aleksandra Banaszkiewicz, Marcin Banasiuk Published: 2025 ABSTRACT AbstractIntroductionThree-dimensional high-resolution anorectal manometry (3D HRAM) is a minimally invasive test allowing the assessment of lower gastrointestinal tract function. Nowadays, it is performed in left lateral or supine position (non-physiological) in accordance with the London Protocol. 3D HRAM can disclose pathological defecation model such as dyssynergic defecation (DD) that might be a cause of constipation in a significant percentage of patients.3D HRAM in healthy adults in lying position shows up to 67%–87% abnormal results during the bear-down manoeuvre; it may result from the non-physiological position taken during the examination.The aim of this study is to assess the influence of body position on parameters of the bear-down manoeuvre during 3D HRAM in children with constipation and healthy volunteers.Methods and analysisThis is a prospective, case-control study. Study participants of 5–18 years old will be recruited and divided into two groups: (I) patients with functional constipation and non-retentive faecal incontinence diagnosed according to the Rome IV criteria and (II) healthy controls. Tests will be performed both in supine and sitting positions, successively using 3D HRAM. The order in which the examination will be performed will be in accordance with the randomisation list generated by computer.The primary endpoint of the study is the difference in the number of patients with DD detected in the sitting and supine positions.Ethics and disseminationThe study was approved by the Ethics Committee of the Medical University of Warsaw, Poland (KB/178/2019). The results of this study will be submitted to a peer-reviewed journal no later than 1 year after data collection. The abstract will be presented at relevant national and international conferences.Trial registration numberNCT06924957.Keywords: GASTROENTEROLOGY, Paediatric gastroenterology, Functional bowel disorders STRENGTHS AND LIMITATIONS OF THIS STUDY The equipment that will be used during the study (Manoscan 360 3D, Medtronic, Duluth, USA) is the most precise, the most advanced system of this type used in clinical practice. The equipment that will be used during the study (Manoscan 360 3D, Medtronic, Duluth, USA) is the most precise, the most advanced system of this type used in clinical practice. The study will also be conducted on healthy volunteers. The study will also be conducted on healthy volunteers. This is a single-centre study that will include only children from Poland. This is a single-centre study that will include only children from Poland. All the examinations will be performed and analysed by only one doctor — that may limit the generalisability of results, but it can also increase the repeatability of results. All the examinations will be performed and analysed by only one doctor — that may limit the generalisability of results, but it can also increase the repeatability of results. Due to the intimate character of the test, recruitment of healthy volunteers (especially in such high numbers) might be impossible to reach. Due to the intimate character of the test, recruitment of healthy volunteers (especially in such high numbers) might be impossible to reach. Introduction Functional disorders of the lower gastrointestinal (GI) tract, including functional constipation (FC), are common reasons for consultations with paediatric gastroenterologists. Anorectal manometry is a minimally invasive, standardised test performed by placing a catheter in the rectum. This allows the assessment of the lower GI tract function by measuring pressure activity.1 Three-dimensional high-resolution anorectal manometry (3D HRAM) is the most advanced system of this type used in clinical practice.2 3D HRAM is normally conducted in unphysiological, lying (supine or left lateral) position. It can be used to diagnose lower GI functional disorders such as FC and non-retentive faecal incontinence (NRFI) and congenital anomalies including Hirschsprung’s disease. Anorectal manometry is also useful for postoperative evaluation of sphincter function in patients with congenital defects such as anorectal atresia.3 Abnormal defecation dynamics can be assessed in detail using 3D HRAM, which can identify impaired relaxation or paradoxical contraction of pelvic floor muscles and inadequate propulsive forces during the bearing-down manoeuvre. Together, these findings are characteristic of dyssynergic defecation (DD).4 Dyssynergia of the pelvic floor during defecation may be a cause of constipation in a significant percentage of patients.5,7 Despite the simplicity of the manometric test and ease of data interpretation, most research on standards or the influence of age and sex on anorectal manometry parameters has been performed on adult populations.8 Moreover, much data are derived from manometry catheters used before the introduction of the more advanced 3D HRAM. Recently, the volume of research conducted in the paediatric population has been increasing. Few studies have been performed to date comparing pressure values during the bear-down manoeuvre in sitting and lying positions. Rao et al9 reported that healthy adult volunteers exhibited DD significantly more frequently when tested in the supine position than in the sitting position (36% vs 20%). Su et al10 showed that a too-low propulsive force was a source of false-positive results. In the study by Wu et al11 the sitting position not only significantly affected propulsive force but also had a significant impact on the percentage of anal canal relaxation and the rectoanal pressure gradient during the bear-down manoeuvre. Patients with FC presented inadequate relaxation of the anal canal significantly more frequently, a feature more visible in the sitting position. The rectoanal pressure gradient evaluated in the sitting (but not lying) position significantly correlates with effective defecation assessed by the balloon expulsion test. However, Osatakul et al12 ascertained that there were no significant differences between sitting and lying positions among patients with FC in the prevalence of DD detected during attempted defecation with an empty rectum. Most of the patients who were diagnosed with DD during previous tests had normal defecation dynamics when given a simulated defecation test. A study in healthy adults using 3D HRAM showed that the percentage of abnormal results during the bear-down manoeuvre in the supine position can reach as high as 67%–87%.13 14 This high percentage of false positive results may result from a non-physiological position during the examination. No similar scientific research has been performed in children to date. The aim of this study is to assess the influence of body position on parameters of bear-down manoeuvre during 3D HRAM in children with FC and healthy volunteers. Methods and analysis Our research plan adheres to the Standard Protocol Items: Recommendations for Interventional Trial 2025.15 Study objectives The aim of this study is to assess the influence of body position on parameters of bear-down manoeuvre during 3D HRAM in children with FC and healthy volunteers. The results of this study might help to determine the reference pressure values obtained in a sitting position during 3D HRAM in paediatric populations (with and without FC/NRFI). Moreover, these results could allow for the more precise diagnosis of patients with incorrect defecation dynamics (such as DD) and improve the identification of patients who could benefit from certain types of treatment, such as biofeedback therapy. Study design This is a prospective, single-centre case-control study with defined study and control groups. Study settings and recruitment Recruitment of patients (both study and control group) will take place at the Department of Paediatric Gastroenterology—the tertiary referral clinic of the Medical University of Warsaw, Poland. Recruitment has already started in January 2020 and should be completed over 6 years (January 2026). Inclusion criteria In both groups, a mandatory criterion for inclusion is written consent to participate in the study from a parent or legal guardian. In cases of children≥16 years old, the child’s written consent is also required. All the participants will be between 5 and 18 years old. Study group Patients with FC or NRFI diagnosed based on Rome IV criteria will be asked to participate in the study. Control group Participants in the control group cannot report symptoms from lower GI like constipation and faecal incontinence. Patients with chronic diseases directly not connected with GI (eg, diabetes, food allergies and asthma), when they are in clinical remission, can be included in this study. Exclusion criteria study and control group Children who have undergone surgeries due to congenital anomalies in the lower GI, or have been diagnosed with inflammatory bowel diseases, inflammation of the large intestine with a different aetiology, anal fissure, inflammation of the anal area and patient with behavioural issues, for example, neurodiverse children or other conditions which could affect the functioning of the distal GI, will be excluded from the study. Intervention Participants will undergo 3D HRAM, following the London Protocol. It is presented in figure 1.16 We will use the Manoscan 360 3D (Medtronic, Duluth, USA) probe that provides a continuous and dynamic spatiotemporal mapping of anorectal pressures.2 17 This system operates with a rigid probe of a greater diameter. The catheter consists of 256 sensors that assess longitudinally and circumferentially pressure in the rectum and is able to produce detailed three-dimensional maps of obtained results. This allows for more detailed data acquisition and easier interpretation of results. There is a lumen inside the probe through which air can be administered into the balloon (3.3 cm in length), allowing for the measurement of the rectoanal inhibitory reflex (RAIR) and intrarectal pressure. The catheter is connected to a recorder and amplifier system (ManoScan A120; Medtronic, Duluth, USA). The London protocol.16 RAIR, rectoanal inhibitory reflex. Experience in our Department indicates that a supine position, with maintained eye contact between patient and doctor, allows for easier cooperation during examination. This aspect is crucial to alleviate stress during the procedure, especially for younger patients. Each subsequent part of the protocol will be explained before the start, and verbal instructions will be given during manoeuvres. Such steps have been proven to influence results in adults.18 Tests will be performed both in supine and sitting positions, successively using 3D HRAM. During the sitting position, we use an adjustable sanitary toilet chair. For younger children, we also use plastic toilet seat covers. The order in which the examination will be performed will be in accordance with the randomisation list generated by https://www.sealedenvelope.com/. The summary of the study design is presented in figure 2. Study design. 3D HRAM, three-dimensional high-resolution anorectal manometry; FC, functional constipation; NRFI, non-retentive faecal incontinence. In the supine position, the following parameters will be recorded: resting pressure, squeeze pressure, endurance squeeze pressure and the bear-down manoeuvre variables. We will also assess the presence of RAIR, rectal sensory thresholds and anal pressure during cough. In the sitting position, after 2–3 min time of adaptation to the probe, the resting pressure, squeeze pressure (two attempts, 5 s each) and the bear-down manoeuvre variables (two attempts, 15 s each) will be recorded. Diagnosis of DD will be made according to the Rao Criteria19: ≤20% relaxation of the anal sphincter and/or intrarectal pressure ≥40 mm Hg during the bear-down manoeuvre (in both positions). Sample size The sample size was calculated to detect a 45% difference in the percentage of patients with a negative rectoanal gradient.20 Equal groups were assumed, with alpha=0.05, beta=0.1 and a 30% dropout percentage. A sample size of 30 participants was determined for both study and control groups. Due to possible age-related differences, two separate age groups were decided: younger, 5–10 years old, and older, 11–18 years old. The total number of patients in the study will therefore be 120 people. Outcomes Primary end point The difference in the number of patients with DD (defined as ≤20% relaxation of anal sphincter and/or intrarectal pressure ≥40 mm Hg during bear down manoeuvre) in sitting and lying position in the study and control group. Secondary end point Values of manometric parameters obtained during 3D HRAM procedure, that is, mean resting pressure of the anal sphincter (mm Hg), maximum squeeze pressure (mm Hg), mean anal canal length (cm) the assessment of parameters of defecation dynamics during 3D HRAM: percentage of anal relaxation rate, residual anal pressure, rectoanal pressure gradient. All secondary end points will be assessed in sitting and lying position in two groups. Statistical analysis Data collection and management Each study participant will be assigned a study identification number. A participant’s case report form (CRF) containing the participant’s identification number and necessary baseline data will be completed in paper form. All data will be checked for completeness, entered and stored in a password-protected electronic database. All original copies of CRFs and all study data in paper form will be stored in a locker within the study site, available for the involved researchers only. Each CRF must be completed, checked for completeness of data and signed by a researcher. Only the research team and person responsible for statistical analysis of the data will have access to the full trial dataset (blinded of any identifying participant). The personal information of the participants will be kept confidential, and only authorised personnel will have access to it. Data analysis The statistical analysis will be conducted in Statistica 13 (Tulsa, Oklahoma, USA) and the Zestaw Plus add-on (Statsoft, Krakow, Poland). The Student’s t-test will be used to compare the means of continuous variables that exhibit a normal distribution. In cases where the continuous variables are not normally distributed, the Mann-Whitney U test will be used instead. To compare percentages, the appropriate statistical test will be employed, either the χ2 test or Fisher’s exact test. For continuous outcomes, the differences in means or medians (depending on the distribution of data) and for dichotomous outcomes, the relative risk (RR) and number needed to treat, all accompanied by a 95% CI, will be calculated. The difference between study groups will be considered statistically significant if the p value is less than 0.05, if the 95% CI for RR does not include 1.0, or if the 95% CI for mean difference does not include 0. All statistical tests will be two-tailed and performed at the 5% level of significance. Missing data Every effort will be made to minimise missing baseline and outcome data. However, the amount of missing data will be reported for each study arm. The reasons for withdrawals, if feasible, will be compared qualitatively between groups. Multiple imputation methods for missing data will be included to address any missing data, as recommended. Patient and public involvement None. Ethics and dissemination The study was approved by the Ethics Committee of the Medical University of Warsaw, Poland (KB/178/2019). This study adheres to the tenets of the Declaration of Helsinki. This study is registered at clinicaltrials.gov (NCT06924957). Before enrolment, a written consent from a parent or legal guardian will be obtained. In cases of children≥16 years and older, the child’s written consent will also be required. Participants will be given a paper copy of the participant informed consent, ensuring they fully understand the study objectives, potential risks, benefits and their right to withdraw at any time without affecting their standard medical care. Confidentiality of patient data will be strictly maintained following data protection regulations, and all identifiable patient information will be securely stored and anonymised for data analysis. This study does not involve animal subjects. The results of this study will be submitted to a peer-reviewed journal no later than 1 year after data collection. The abstract will be presented at relevant national and international conferences. Footnotes Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Prepub: Prepublication history for this paper is available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2025-112928). Patient consent for publication: Not applicable. Provenance and peer review: Not commissioned; externally peer reviewed. Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research. References